Faheem Hasnain, President & CEO, Director at Receptos, holds 23.98K shares in Kura Oncology (Ticker: KURA), holds 5.53M shares in Gossamer Bio (Ticker: GOSS), holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX).
Faheem Hasnain latest transaction was an Uninformative Buy of $143.35K.
What was Faheem Hasnain's most profitable transaction?
Faheem Hasnain’s most profitable transaction was an Informative Buy of GOSS stock on June 24, 2024. The return on the trade was 67.00%.
What is Faheem Hasnain's role in Receptos?
Faheem Hasnain's role in Receptos is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.